Research team from University of Göttingen develops drug approach against bacterial infections
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago. Many diseases caused by bacterial infections – such as pneumonia, meningitis or septicaemia – are successfully treated with antibiotics. However, bacteria can develop resistance to antibiotics which then leaves doctors struggling to find effective treatments. Particularly problematic are pathogens which develop multi-drug resistance and are unaffected by most antibiotics. This leads to severe disease progression in affected patients, often with a fatal outcome. Scientists all over the world are therefore engaged in the search for new antibiotics. Researchers at the University of Göttingen and the Max Planck Institute for Biophysical Chemistry Göttingen have now described a promising new approach involving “antivitamins” to develop new classes of antibiotics. The results were published in the journal Nature Chemical Biology.
Antivitamins are substances that inhibit the biological function of a genuine vitamin. Some antivitamins have a similar chemical structure to those of the actual vitamin whose action they block or restrict. For this study, Professor Kai Tittmann’s team from the Göttingen Center for Molecular Biosciences at the University of Göttingen worked together with Professor Bert de Groot’s group from the Max Planck Institute for Biophysical Chemistry Göttingen and Professor Tadgh Begley from Texas A&M University (USA). Together they investigated the mechanism of action at the atomic level of a naturally occurring antivitamin of vitamin B1. Some bacteria are able to produce a toxic form of this vital vitamin B1 to kill competing bacteria. This particular antivitamin has only a single atom in addition to the natural vitamin in a seemingly unimportant place and the exciting research question was why the action of the vitamin was still prevented or “poisoned”.
Tittmann’s team used high-resolution protein crystallography to investigate how the antivitamin inhibits an important protein from the central metabolism of bacteria. The researchers found that the “dance of the protons”, which can normally be observed in functioning proteins, almost completely ceases to function and the protein no longer works. “Just one extra atom in the antivitamin acts like a grain of sand in a complex gear system by blocking its finely tuned mechanics,” explains Tittmann. It is interesting to note that human proteins are able to cope relatively well with the antivitamin and continue working. The chemist de Groot and his team used computer simulations to find out why this is so. “The human proteins either do not bind to the antivitamin at all or in such a way that they are not ‘poisoned’,” says the Max Planck researcher. The difference between the effects of the antivitamin on bacteria and on human proteins opens up the possibility of using it as an antibiotic in the future and thus creating new therapeutic alternatives.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Dietary Supplements and Minerals Newson September 30, 2020 at 5:00 pm
Sep. 9, 2020 — A research group has now developed a hypothesis whereby iron deposits in the brain -- resulting from alcohol-induced vitamin B1 deficiency -- can be ... Sep. 30, 2020 — Rapeseed ...
- Microbes and More Newson September 30, 2020 at 5:00 pm
Sep. 28, 2020 — A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a new ... Oct. 1, 2020 ...
- Antibiotics Newson April 29, 2012 at 7:47 am
Are antivitamins the solution to the antimicrobial resistance problem? Microbiologists have now identified a new approach that involves 'antivitamins', and these are said to hold promise with the ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Study shows antibiotics may be viable treatment option for appendicitison October 6, 2020 at 2:21 pm
In the largest randomized US study of appendicitis, researchers report that seven in 10 patients who received antibiotics avoided surgery and that patients who took antibiotics for symptom relief ...
- Antibiotics May Be Best First Treatment for Appendicitison October 6, 2020 at 12:13 pm
For some patients suffering from appendicitis, antibiotics may do the trick, a large U.S. trial suggests. More than 70% of patients who received antibiotics avoided surgery for at least 90 days, ...
- Surgery or Antibiotics for Appendicitis?on October 6, 2020 at 8:39 am
It used to be that just about everyone had their appendix removed during childhood. It was almost a rite of passage. But not everyone needs surgery.
- New antibiotics: Turning to dirt in the fight against drug-resistant bacteriaon October 6, 2020 at 1:28 am
Dirt contains an entire microbial ecosystem, with a wealth of intriguing compounds. And while there are major hurdles between discovering a new drug and using it, scientists are hopeful new techniques ...
- CODA trial shows antibiotics may be a good choice for certain patients with appendicitison October 5, 2020 at 10:55 pm
Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from the Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) Trial reported today in ...